Looking beyond the spin of Big Pharma PR. But encouraging gossip. Come in and confide, you know you want to! “I’ll publish right or wrong. Fools are my theme, let satire be my song.”
Email: jackfriday2011(at)hotmail.co.uk
Thursday, April 23, 2009
BMS - Onglyza: three more months
U.S. regulators need more time to review the new diabetes drug Onglyza from AstraZeneca and Bristol-Myers Squibb.
The FDA has delayed a decision on whether the product should be approved by three months to July 30th.
No comments:
Post a Comment